已收盘 12-19 16:00:00 美东时间
+1.690
+2.54%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
今日重点评级关注:HC Wainwright & Co.:维持Moleculin Biotech"买入"评级,目标价从4美元升至22美元;HC Wainwright & Co.:上调Soluna Holdings评级至"买入",目标价5美元
12-12 10:24
RBC Capital analyst Luca Issi maintains Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and raises the price target from $52 to $80.
12-11 23:19
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Arrowhead Pharmaceuticals shares are trading higher. Yesterday, the company ann...
12-04 00:02
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
今日重点评级关注:RBC Capital:上调Neumora Therapeutics评级至"跑赢大市",目标价从4美元升至7美元;HC Wainwright & Co.:维持ProMIS Neurosciences"买入"评级,目标价从4美元升至18美元
12-02 09:50
Arrowhead制药飙升23%,行业首个微粒血症商用药物获FDA批准,最新财报强劲超预期;DeFi大涨20%,公司宣布QCAD数字信托获批为加拿大首个合规的加元稳定币>>
11-27 16:04
Arrowhead shares are trading higher Wednesday after the company reported better-than-expected fourth quarter financial results.
11-27 04:59
Arrowhead Pharmaceuticals shares are trading higher after the company repeorted...
11-26 23:42